The analysis results indicated that there was no obvious difference shown in different molecular subtypes (Additional file 1: Fig. S2A), but for immune subtypes, RPLP2 expression was significantly different in HCC (Additional file 1: Fig. S2B). The gene discussed is RPLP2; the disease is hepatocellular carcinoma.